Skip to content

Clinical and cost-effectiveness of collaborative Korean and Western medicine treatment for chronic low back pain - A prospective observational study

Clinical and cost-effectiveness of collaborative Korean and Western medicine treatment for chronic low back pain - A prospective observational study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0010872
Enrollment
312
Registered
2025-08-11
Start date
2025-07-22
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Pusan National University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Adult patients aged 19 or older - First-time outpatients at institutions participating in the Korean medicine and Western medicine collaboration Pilot Project, with low back pain related condition - Complained of low back pain for more than three months *Cf - Major diseases causing chronic low back pain : M40-43 Degenerative spine disease M44-49 Spinal disease M53 Other spine diseases M54 Back pain

Exclusion criteria

Exclusion criteria: ? Auto insurance patients† ? Patients expected to be difficult to follow up, due to unstable housing, unclear contact information, etc. ? Patients who may have difficulty understanding and responding to the study questionnaire due to illiteracy, mental incapacity, etc. ? Other patients whom the researcher deems unsuitable for study participation ? Participants in the pilot project for insurance coverage of herbal medicine decoctions†† † Not eligible for the Korean medicine and Western medicine collaboration Pilot Project not eligible for concurrent participation in the 5th phase of the Korean Medicine–Western Medicine Collaboration pilot project.

Design outcomes

Primary

MeasureTime frame
Numeric Rating Scale(NRS);Oswestry Disability Index;EuroQol-5 Dimension;EuroQol-Visual Analogue Scale;Recovery status;Cost per QALYs(Quality Adjusted Life Years);Treatment status; Incremental Cost-Effectiveness Ratio; Incremental Net Benefit;Cost-Effectiveness Acceptability Curve

Secondary

MeasureTime frame
Care pathway and cost data survey

Countries

Korea, Republic of

Contacts

Public ContactLinae Kim

Pusan National University

klinae@pusan.ac.kr+82-55-350-5995

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Jul 23, 2026